Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001073357 | SCV001238897 | likely pathogenic | Retinal dystrophy | 2018-12-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001247223 | SCV001420632 | pathogenic | not provided | 2023-12-07 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 1687 of the ABCA4 protein (p.Ile1687Phe). This variant is present in population databases (rs201996979, gnomAD 0.008%). This missense change has been observed in individuals with retinal disease (PMID: 17932850, 29555955). ClinVar contains an entry for this variant (Variation ID: 865833). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ABCA4 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001247223 | SCV001985367 | uncertain significance | not provided | 2019-05-20 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Identified in individuals with autosomal recessive retinitis pigmentosa and with Stargardt disease in published literature (Stenirri et al., 2007; Birtel et al., 2018); This variant is associated with the following publications: (PMID: 17932850, 29555955, 30140905) |
Fulgent Genetics, |
RCV005029673 | SCV005658764 | likely pathogenic | Cone-rod dystrophy 3; Age related macular degeneration 2; Severe early-childhood-onset retinal dystrophy; Retinitis pigmentosa 19 | 2024-03-31 | criteria provided, single submitter | clinical testing |